Should You Sell Lineage Cell Therapeutics Inc (LCTX) And Go Away This Year?

Lineage Cell Therapeutics Inc (AMEX:LCTX) currently has a daily average trading volume of 2.21M but it saw 2527058 shares traded in last market. With a market cap of 232.92M USD, the company’s current market price of $1.02 came rising about 13.62 while comparing to the previous closing price of $0.9. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.15 and as low as $0.37. In the recent trading on the day, stock has struck highest price mark of $0.9068 while lowest mark touched by it was $1.03.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Craig Hallum which initiated the stock as “Buy” in its note to investors issued on August 20, 2024, recommending a price target of $4 for it. B. Riley Securities also issued its recommendations for the stock as it initiated the price target for the stock is $4.

Over the week, LCTX’s stock price is moving -4.67% down while it is 53.38% when we observe its performance for the past one month. Year-to-date it is 2.28% up and over the past year, the stock is showing an upside performance of 102.99%.

Currently, Lineage Cell Therapeutics Inc’s total number of outstanding shares is 228.36M with 0.42% of that held by the insiders while 47.94% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -20.23% and return on equity (ROE) at -21.40%. Stock’s beta reads 1.66. Stock has a price to book (P/B) ratio of 2.95 while price to sale or P/S ratio amounts to 24.36. Its return on asset (ROA) is -14.72% on average.

#

Comet Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.